Accuray To Participate In Upcoming Investor Conferences

SUNNYVALE, Calif., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in three upcoming investor conferences.

Accuray management is scheduled to present at the Citi 2014 Global Healthcare Conference in New York on Wednesday, February 26, 2014 at 1:00pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

Accuray management is scheduled to present at the Cowen 34 th Annual Healthcare Conference in Boston on Wednesday, March 5, 2014 at 9:20am ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

Accuray management is also scheduled to participate in the Morgan Stanley Medtech & Services Conference in London on Wednesday, March 5, 2014.

About Accuray

Accuray Incorporated (Nasdaq:ARAY), is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com .
CONTACT: Investors: Lynn Pieper         Investor Relations, Westwicke Partners         +1 (415) 202-5678         lynn.pieper@westwicke.com                  Media: Madelyn Homick         Manager Communications, Accuray         +1 (408) 789-4335         mhomick@accuray.com

If you liked this article you might like

Accuray (ARAY) Stock Sharply Lower After Q4 Results, Guidance

Will Accuray (ARAY) Stock Fall on Q4 Miss, Downbeat Outlook?

Trade These 5 Biotech Breakouts Now for Big Gains

Accuray (ARAY) Strong On High Relative Volume Today

Accuray (ARAY) Highlighted As Weak On High Volume